Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.
Within the past 20 years, the field of precision medicine has been transformed. For biotech co...
Contact Us with your Biotech needs!Email Us
Other content in this Stream
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
Learn more about how to address operational challenges that come with harnessing RWD.
Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.
Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing
Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.
Learn about the benefits that real-world evidence (RWE) can bring to small & mid-size biotech companies.
For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.
The COVID-19 global pandemic has had a significant impact on the conduct of pediatric and adult clinical drug trials. Many trials have halted enrollment, and there are multiple challenges with...
In clinical trials for cellular and gene therapies, the COVID-19 pandemic has created enormous complexities. Parexel experts Matthew M. Cooney, MD and Roberta L. Steere offer a brief overview.
For over three months the world has been battling COVID-19. COVID-19 is unforgiving and has the ability to overwhelm even the strongest health system or regulatory regime. Even though the...
Learn more about key considerations when selecting the right wearable device for your clinical trial.
Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more...
Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for regulatory bodies.
This PharmaVoice podcast explores patient-centric trials as a key innovation in drug development.
Harness precision medicine innovations to bring treatments to patients faster.
Learn how Parexel can help you successfully implement Adaptive Trial Designs.